Yungjin Pharm. Co., Ltd. (KRX: 003520)
South Korea
· Delayed Price · Currency is KRW
1,907.00
-73.00 (-3.69%)
Dec 20, 2024, 3:30 PM KST
Yungjin Pharm. Revenue
Yungjin Pharm. had revenue of 38.98B KRW in the quarter ending September 30, 2013, with 4.67% growth. This brings the company's revenue in the last twelve months to 158.79B, up 23.36% year-over-year. In the year 2012, Yungjin Pharm. had annual revenue of 137.69B with 22.82% growth.
Revenue (ttm)
158.79B
Revenue Growth
+23.36%
P/S Ratio
1.91
Revenue / Employee
276.63M
Employees
574
Market Cap
348.78B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2012 | 137.69B | 25.58B | 22.82% |
Dec 31, 2011 | 112.11B | -4.21B | -3.62% |
Dec 31, 2010 | 116.32B | 12.94B | 12.52% |
Dec 31, 2009 | 103.38B | -7.53B | -6.79% |
Dec 31, 2008 | 110.91B | 1.25B | 1.14% |
Dec 31, 2007 | Pro | Pro | Pro |
Dec 31, 2006 | Pro | Pro | Pro |
Dec 31, 2005 | Pro | Pro | Pro |
Dec 31, 2004 | Pro | Pro | Pro |
Dec 31, 1999 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition